{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19656383", "DateCompleted": {"Year": "2009", "Month": "10", "Day": "19"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2009", "Month": "08", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1186/1472-6882-9-29"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2009", "Month": "Aug", "Day": "05"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plants.", "Pagination": {"StartPage": "29", "MedlinePgn": "29"}, "Abstract": {"AbstractText": ["Highly active anti-retroviral therapy (HAART) is the current HIV/AIDS treatment modality. Despite the fact that HAART is very effective in suppressing HIV-1 replication and reducing the mortality of HIV/AIDS patients, it has become increasingly clear that HAART does not offer an ultimate cure to HIV/AIDS. The high cost of the HAART regimen has impeded its delivery to over 90% of the HIV/AIDS population in the world. This reality has urgently called for the need to develop inexpensive alternative anti-HIV/AIDS therapy. This need has further manifested by recent clinical trial failures in anti-HIV-1 vaccines and microbicides. In the current study, we characterized a panel of extracts of traditional Chinese medicinal herbal plants for their activities against HIV-1 replication.", "Crude and fractionated extracts were prepared from various parts of nine traditional Chinese medicinal herbal plants in Hainan Island, China. These extracts were first screened for their anti-HIV activity and cytotoxicity in human CD4+ Jurkat cells. Then, a single-round pseudotyped HIV-luciferase reporter virus system (HIV-Luc) was used to identify potential anti-HIV mechanisms of these extracts.", "Two extracts, one from Euphorbiaceae, Trigonostema xyphophylloides (TXE) and one from Dipterocarpaceae, Vatica astrotricha (VAD) inhibited HIV-1 replication and syncytia formation in CD4+ Jurkat cells, and had little adverse effects on host cell proliferation and survival. TXE and VAD did not show any direct inhibitory effects on the HIV-1 RT enzymatic activity. Treatment of these two extracts during the infection significantly blocked infection of the reporter virus. However, pre-treatment of the reporter virus with the extracts and treatment of the extracts post-infection had little effects on the infectivity or gene expression of the reporter virus.", "These results demonstrate that TXE and VAD inhibit HIV-1 replication likely by blocking HIV-1 interaction with target cells, i.e., the interaction between gp120 and CD4/CCR5 or gp120 and CD4/CXCR4 and point to the potential of developing these two extracts to be HIV-1 entry inhibitors."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. parki@iupui.edu"}], "Identifier": [], "LastName": "Park", "ForeName": "In-Woo", "Initials": "IW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Han", "ForeName": "Changri", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Song", "ForeName": "Xiaoping", "Initials": "X"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Green", "ForeName": "Linden A", "Initials": "LA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Ting", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Ying", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cen", "ForeName": "Changchun", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Song", "ForeName": "Xinming", "Initials": "X"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yang", "ForeName": "Biao", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chen", "ForeName": "Guangying", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "He", "ForeName": "Johnny J", "Initials": "JJ"}], "GrantList": [{"GrantID": "R21 DA022986", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}, {"GrantID": "R21 DA025487", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}, {"GrantID": "R21DA025487", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}, {"GrantID": "R21DA022986", "Acronym": "DA", "Agency": "NIDA NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-HIV Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-HIV Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "CD4-Positive T-Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Dipterocarpaceae"}, {"QualifierName": [], "DescriptorName": "Euphorbiaceae"}, {"QualifierName": ["drug effects", "virology"], "DescriptorName": "Giant Cells"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "HIV Infections"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Jurkat Cells"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science. 1983;220:868\u2013871. doi: 10.1126/science.6189183.", "ArticleIdList": ["10.1126/science.6189183", "6189183"]}, {"Citation": "Broder S, Gallo RC. A pathogenic retrovirus (HTLV-III) linked to AIDS. N Engl J Med. 1984;311:1292\u20131297.", "ArticleIdList": ["6208484"]}, {"Citation": "Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, Sweet RW. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature. 1988;331:82\u201384. doi: 10.1038/331082a0.", "ArticleIdList": ["10.1038/331082a0", "3257544"]}, {"Citation": "Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem. 2001;70:777\u2013810. doi: 10.1146/annurev.biochem.70.1.777.", "ArticleIdList": ["10.1146/annurev.biochem.70.1.777", "11395423"]}, {"Citation": "Platt EJ, Durnin JP, Kabat D. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus. J Virol. 2005;79:4347\u20134356. doi: 10.1128/JVI.79.7.4347-4356.2005.", "ArticleIdList": ["10.1128/JVI.79.7.4347-4356.2005", "PMC1061535", "15767435"]}, {"Citation": "Ray N, Doms RW. HIV-1 coreceptors and their inhibitors. Curr Top Microbiol Immunol. 2006;303:97\u2013120. full_text.", "ArticleIdList": ["16570858"]}, {"Citation": "Coffin J, Hiughes S, Varmus H. Retroviruses. Plainview, NY, USA: Cold Spring Harbor Laboratory Press; 1997.", "ArticleIdList": ["21433340"]}, {"Citation": "Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2004;2:E234. doi: 10.1371/journal.pbio.0020234.", "ArticleIdList": ["10.1371/journal.pbio.0020234", "PMC509299", "15314653"]}, {"Citation": "Scherdin U, Rhodes K, Breindl M. Transcriptionally active genome regions are preferred targets for retrovirus integration. J Virol. 1990;64:907\u2013912.", "ArticleIdList": ["PMC249188", "2296087"]}, {"Citation": "Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521\u2013529. doi: 10.1016/S0092-8674(02)00864-4.", "ArticleIdList": ["10.1016/S0092-8674(02)00864-4", "12202041"]}, {"Citation": "Bieniasz PD. Late budding domains and host proteins in enveloped virus release. Virology. 2006;344:55\u201363. doi: 10.1016/j.virol.2005.09.044.", "ArticleIdList": ["10.1016/j.virol.2005.09.044", "16364736"]}, {"Citation": "Martin-Serrano J, Zang T, Bieniasz PD. Role of ESCRT-I in retroviral budding. J Virol. 2003;77:4794\u20134804. doi: 10.1128/JVI.77.8.4794-4804.2003.", "ArticleIdList": ["10.1128/JVI.77.8.4794-4804.2003", "PMC152150", "12663786"]}, {"Citation": "Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 1993;261:1179\u20131181. doi: 10.1126/science.8356453.", "ArticleIdList": ["10.1126/science.8356453", "8356453"]}, {"Citation": "Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450\u2013454. doi: 10.1001/jama.279.6.450.", "ArticleIdList": ["10.1001/jama.279.6.450", "9466638"]}, {"Citation": "Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998;352:1725\u20131730. doi: 10.1016/S0140-6736(98)03201-2.", "ArticleIdList": ["10.1016/S0140-6736(98)03201-2", "9848347"]}, {"Citation": "Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853\u2013860. doi: 10.1056/NEJM199803263381301.", "ArticleIdList": ["10.1056/NEJM199803263381301", "9516219"]}, {"Citation": "Chou R, Huffman LH, Fu R, Smits AK, Korthuis PT. Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;143:55\u201373.", "ArticleIdList": ["15998755"]}, {"Citation": "Hawkins T. Appearance-related side effects of HIV-1 treatment. AIDS Patient Care STDS. 2006;20:6\u201318. doi: 10.1089/apc.2006.20.6.", "ArticleIdList": ["10.1089/apc.2006.20.6", "16426151"]}, {"Citation": "d'Arminio Monforte A, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G, Colangeli V, De Luca A, Ippolito G, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients. Aids. 2000;14:499\u2013507. doi: 10.1097/00002030-200003310-00005.", "ArticleIdList": ["10.1097/00002030-200003310-00005", "10780712"]}, {"Citation": "Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC. HIV vaccine research: the way forward. Science. 2008;321:530\u2013532. doi: 10.1126/science.1161000.", "ArticleIdList": ["10.1126/science.1161000", "18653883"]}, {"Citation": "Mauck CK, Straten AV. Using Objective Markers to Assess Participant Behavior in HIV Prevention Trials of Vaginal Microbicides. J Acquir Immune Defic Syndr. 2008;49:64\u20139. doi: 10.1097/QAI.0b013e318183a917.", "ArticleIdList": ["10.1097/QAI.0b013e318183a917", "18667920"]}, {"Citation": "Sekaly RP. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J Exp Med. 2008;205:7\u201312. doi: 10.1084/jem.20072681.", "ArticleIdList": ["10.1084/jem.20072681", "PMC2234358", "18195078"]}, {"Citation": "Van Damme L, Govinden R, Mirembe FM, Guedou F, Solomon S, Becker ML, Pradeep BS, Krishnan AK, Alary M, Pande B, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med. 2008;359:463\u2013472. doi: 10.1056/NEJMoa0707957.", "ArticleIdList": ["10.1056/NEJMoa0707957", "18669425"]}, {"Citation": "Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, Fenyo EM. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol. 1997;71:7478\u20137487.", "ArticleIdList": ["PMC192094", "9311827"]}, {"Citation": "Li J, Liu Y, Park IW, He JJ. Expression of exogenous Sam68, the 68-kilodalton SRC-associated protein in mitosis, is able to alleviate impaired Rev function in astrocytes. J Virol. 2002;76:4526\u20134535. doi: 10.1128/JVI.76.9.4526-4535.2002.", "ArticleIdList": ["10.1128/JVI.76.9.4526-4535.2002", "PMC155096", "11932418"]}, {"Citation": "Liu Y, Kim BO, Kao C, Jung C, Dalton JT, He JJ. Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa, is a negative regulator of androgen receptor (AR) transcription activation. J Biol Chem. 2004;279:21766\u201373. doi: 10.1074/jbc.M314321200.", "ArticleIdList": ["10.1074/jbc.M314321200", "15031286"]}, {"Citation": "He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 1997;385:645\u2013649. doi: 10.1038/385645a0.", "ArticleIdList": ["10.1038/385645a0", "9024664"]}, {"Citation": "Li J, Liu Y, Kim BO, He JJ. Direct participation of Sam68, the 68-kilodalton Src-associated protein in mitosis, in the CRM1-mediated Rev nuclear export pathway. J Virol. 2002;76:8374\u20138382. doi: 10.1128/JVI.76.16.8374-8382.2002.", "ArticleIdList": ["10.1128/JVI.76.16.8374-8382.2002", "PMC155124", "12134041"]}, {"Citation": "Xiang YZ, Shang HC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother Res. 2008;22:851\u2013858. doi: 10.1002/ptr.2384.", "ArticleIdList": ["10.1002/ptr.2384", "18567057"]}, {"Citation": "He J, Landau NR. Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor. J Virol. 1995;69:4587\u20134592.", "ArticleIdList": ["PMC189211", "7769729"]}, {"Citation": "Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 1996;85:1149\u20131158. doi: 10.1016/S0092-8674(00)81314-8.", "ArticleIdList": ["10.1016/S0092-8674(00)81314-8", "8674120"]}, {"Citation": "De Clercq E. New developments in anti-HIV chemotherapy. Biochim Biophys Acta. 2002;1587:258\u2013275.", "ArticleIdList": ["12084468"]}, {"Citation": "De Clercq E. The design of drugs for HIV and HCV. Nat Rev Drug Discov. 2007;6:1001\u20131018. doi: 10.1038/nrd2424.", "ArticleIdList": ["10.1038/nrd2424", "18049474"]}, {"Citation": "Gore-Felton C, Vosvick M, Power R, Koopman C, Ashton E, Bachmann MH, Israelski D, Spiegel D. Alternative therapies: a common practice among men and women living with HIV. J Assoc Nurses AIDS Care. 2003;14:17\u201327. doi: 10.1177/1055329003014003002.", "ArticleIdList": ["10.1177/1055329003014003002", "12800809"]}, {"Citation": "Josephs JS, Fleishman JA, Gaist P, Gebo KA. Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS. HIV Med. 2007;8:300\u2013305. doi: 10.1111/j.1468-1293.2007.00474.x.", "ArticleIdList": ["10.1111/j.1468-1293.2007.00474.x", "17561876"]}, {"Citation": "De Clercq E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev. 2000;20:323\u2013349. doi: 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A.", "ArticleIdList": ["10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A", "10934347"]}, {"Citation": "Gochfeld DJ, El Sayed KA, Yousaf M, Hu JF, Bartyzel P, Dunbar DC, Wilkins SP, Zjawiony JK, Schinazi RF, Schlueter Wirtz S, et al. Marine natural products as lead anti-HIV agents. Mini Rev Med Chem. 2003;3:401\u2013424. doi: 10.2174/1389557033487962.", "ArticleIdList": ["10.2174/1389557033487962", "12769693"]}, {"Citation": "Tziveleka LA, Vagias C, Roussis V. Natural products with anti-HIV activity from marine organisms. Curr Top Med Chem. 2003;3:1512\u20131535. doi: 10.2174/1568026033451790.", "ArticleIdList": ["10.2174/1568026033451790", "14529524"]}, {"Citation": "Gustafson KR, Sowder RC, 2nd, Henderson LE, Cardellina JH, 2nd, McMahon JB, Rajamani U, Pannell LK, Boyd MR. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum. Biochem Biophys Res Commun. 1997;238:223\u2013228. doi: 10.1006/bbrc.1997.7203.", "ArticleIdList": ["10.1006/bbrc.1997.7203", "9299483"]}, {"Citation": "Dey B, Lerner DL, Lusso P, Boyd MR, Elder JH, Berger EA. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses. J Virol. 2000;74:4562\u20134569. doi: 10.1128/JVI.74.10.4562-4569.2000.", "ArticleIdList": ["10.1128/JVI.74.10.4562-4569.2000", "PMC111976", "10775592"]}, {"Citation": "Esser MT, Mori T, Mondor I, Sattentau QJ, Dey B, Berger EA, Boyd MR, Lifson JD. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J Virol. 1999;73:4360\u20134371.", "ArticleIdList": ["PMC104217", "10196334"]}, {"Citation": "Au TK, Lam TL, Ng TB, Fong WP, Wan DC. A comparison of HIV-1 integrase inhibition by aqueous and methanol extracts of Chinese medicinal herbs. Life Sci. 2001;68:1687\u20131694. doi: 10.1016/S0024-3205(01)00945-6.", "ArticleIdList": ["10.1016/S0024-3205(01)00945-6", "11263681"]}, {"Citation": "Del Beccaro MA, Mendelman PM, Inglis AF, Richardson MA, Duncan NO, Clausen CR, Stull TL. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992;120:81\u201384. doi: 10.1016/S0022-3476(05)80605-5.", "ArticleIdList": ["10.1016/S0022-3476(05)80605-5", "1731029"]}, {"Citation": "Liu J. The use of herbal medicines in early drug development for the treatment of HIV infections and AIDS. Expert Opin Investig Drugs. 2007;16:1355\u20131364. doi: 10.1517/13543784.16.9.1355.", "ArticleIdList": ["10.1517/13543784.16.9.1355", "17714022"]}, {"Citation": "Liu S, Jiang S, Wu Z, Lv L, Zhang J, Zhu Z, Wu S. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte. Life Sci. 2002;71:1779\u20131791. doi: 10.1016/S0024-3205(02)01939-2.", "ArticleIdList": ["10.1016/S0024-3205(02)01939-2", "12151056"]}, {"Citation": "Tang X, Chen H, Zhang X, Quan K, Sun M. Screening anti-HIV Chinese materia medica with HIV and equine infectious anemic virus reverse transcriptase. J Tradit Chin Med. 1994;14:10\u201313.", "ArticleIdList": ["7515133"]}, {"Citation": "Wu JA, Attele AS, Zhang L, Yuan CS. Anti-HIV activity of medicinal herbs: usage and potential development. Am J Chin Med. 2001;29:69\u201381. doi: 10.1142/S0192415X01000083.", "ArticleIdList": ["10.1142/S0192415X01000083", "11321482"]}]}], "History": [{"Year": "2009", "Month": "6", "Day": "19"}, {"Year": "2009", "Month": "8", "Day": "5"}, {"Year": "2009", "Month": "8", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "8", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "10", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2009", "Month": "8", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["19656383", "PMC2736925", "10.1186/1472-6882-9-29", "1472-6882-9-29"]}}], "PubmedBookArticle": []}